Kyprolis and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is found among people who take Kyprolis, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Kyprolis and have Dry skin. It is created by eHealthMe based on reports of 11,801 people who have side effects when taking Kyprolis from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

11,801 people reported to have side effects when taking Kyprolis.
Among them, 16 people (0.14%) have Dry skin.


What is Kyprolis?

Kyprolis has active ingredients of carfilzomib. It is often used in multiple myeloma. eHealthMe is studying from 11,812 Kyprolis users for its effectiveness, alternative drugs and more.

What is Dry skin?

Dry skin is found to be associated with 2,688 drugs and 2,186 conditions by eHealthMe.

Number of Kyprolis and Dry skin reports submitted per year:

Could Kyprolis cause Dry skin?

Time on Kyprolis when people have Dry skin *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Dry skin when taking Kyprolis *:

  • female: 25 %
  • male: 75 %

Age of people who have Dry skin when taking Kyprolis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 11.11 %
  • 60+: 88.89 %

Common drugs people take besides Kyprolis *:

  1. Revlimid: 10 people, 62.50%
  2. Zyrtec: 4 people, 25.00%
  3. Fish Oil: 4 people, 25.00%
  4. Vitamin D3: 3 people, 18.75%
  5. Decadron: 3 people, 18.75%
  6. Crestor: 2 people, 12.50%
  7. Codeine: 2 people, 12.50%
  8. Levaquin: 2 people, 12.50%
  9. Zometa: 2 people, 12.50%
  10. Promethazine: 2 people, 12.50%

Common side effects people have besides Dry skin *:

  1. Diarrhea: 5 people, 31.25%
  2. Fatigue (feeling of tiredness): 4 people, 25.00%
  3. Itching: 4 people, 25.00%
  4. Rashes (redness): 3 people, 18.75%
  5. Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 2 people, 12.50%
  6. Memory Loss: 2 people, 12.50%
  7. Night Sweats (sweating in night): 2 people, 12.50%
  8. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 12.50%
  9. Nausea (feeling of having an urge to vomit): 2 people, 12.50%
  10. Nasopharyngitis (inflammation of the nasopharynx): 2 people, 12.50%

Common conditions people have *:

  1. Diabetes: 3 people, 18.75%
  2. Neuropathy Peripheral (surface nerve damage): 2 people, 12.50%
  3. Nausea (feeling of having an urge to vomit): 2 people, 12.50%
  4. High Blood Cholesterol: 2 people, 12.50%
  5. Herpes Zoster: 2 people, 12.50%
  6. Eye Disorder: 2 people, 12.50%
  7. Cough: 2 people, 12.50%
  8. Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 1 person, 6.25%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.25%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Kyprolis and have Dry skin?

Check whether Dry skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Kyprolis:

Dry skin treatments and more:

COVID vaccines that are related to Dry skin:

How severe was Dry skin and when was it recovered:

Expand to all the drugs that have ingredients of carfilzomib:

Common drugs associated with Dry skin:

All the drugs that are associated with Dry skin:

Common conditions associated with Dry skin:

All the conditions that are associated with Dry skin:

How the study uses the data?

The study uses data from the FDA. It is based on carfilzomib (the active ingredients of Kyprolis) and Kyprolis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: